CTX-712
Treatment Description
CTX-712 is an oral CLK inhibitor being studied for use in several different cancers.
Participating Centers
There are 5 centers running trials with this treatment. Enter a location below to find the closest center.
CTX-712 is an oral CLK inhibitor being studied for use in several different cancers.
There are 5 centers running trials with this treatment. Enter a location below to find the closest center.